UNSPSC 51343112: Navuridine

This classification denotes a pyrimidine antagonist and antiviral agent with the molecular formula C9H11N5O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier PS28W65479. The term NAVURIDINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 15 no. 3-4, 2001, list 46. ). Most nations schedule navuridine under HS 29349990 and SITC 51579. As of Q4 2014, NAVURIDINE remains the US FDA Preferred Term for this commodity. Navuridine bears US NLM identifiers UMLS ID C0046786 and NCI Concept Code C83920.

SMILES: C1C(C(OC1N2C=CC(=O)NC2=O)CO)N=[N+]=[N-].

UNSPSC 51343112 Navuridine, a Commodity code, does not match the state and local procurement activity tagged under it. The two most recent opportunities in the data—a pharmaceutical warehouse piggyback contract through Illinois Department of Public Health for Doxycycline Hyclate and Ciprofloxacin Hydrochloride, and a Seminole County, Florida procurement for Naloxone and Safe Drug Deactivation Systems—bear no relationship to Navuridine, an antiviral nucleoside analog used in HIV treatment. The code shows little relevant recent activity under its nominal scope.

Without current state and local solicitations for Navuridine itself, no issuing-body pattern, geographic concentration, or representative opportunity can be established from the available data. Firms evaluating this code should verify whether state and local procurement offices are actively tagging Navuridine acquisitions separately or whether the drug is being sourced through bundled pharmaceutical contracts, group purchasing organization agreements, or federal supply schedules that state and local jurisdictions access but do not publish independently.